SOURCE: Exlites Holdings International, Inc.

August 22, 2013 07:00 ET

Exlites Announces New Products

SALT LAKE CITY, UT--(Marketwired - Aug 22, 2013) - Exlites Holdings International, Inc. (PINKSHEETS: EXHI) announced today that it has over 20 new medical products that it has made available for sale. Management expects to increase sales by building its product offerings to include the most popular selling and profitable, cost-effective products for customers. The new products include Synthetic Vinyl Gloves, Adhesive Bandages and Stand Blood Pressure Monitors, which have proven to be some of the most popularly requested products in the medical equipment industry.

According to the Frost & Sullivan 2013 outlook study, profitability will depend on developing streamlined market strategies to effectively position medical product offerings for value conscious consumers. (1) Based on recent market reports management believes it is positioning Exlites to provide cost-effective high-technology medical products and devices for its customers. According to research reports in the medical device industry, China, India, Brazil, Russia, and Eastern Europe are expected to offer the most growth opportunities for industry growth in 2013. The Medical Device Industry ranks among the top-five industries for 2013.

Eugene Collins, Director, Business Development, said, "When we seek to source new medical equipment we look for products that offer cutting-edge technology, we look for products that are cost effective alternatives, and we look to obtain the most popular products in the industry. Of course our main objective is high-quality and cost-efficiency," said Johnson.

Exlites was incorporated in the U.S., and until recently, was mainly engaged in business in Japan. Recently, management determined that it was in the Company's best interest to enter the larger U.S. medical equipment market and take advantage of its relationships. Exlites' business model is unique in that the Company strives to provide assistance and resources to certain medical equipment manufacturers, many of whom are overseas, are more cost effective and may require FDA approval. By partnering with these medical equipment companies, Exlites can obtain better pricing for the best quality products for its customers. Exlites' business plan includes assisting manufacturers to obtain FDA registration and approval.

About Exlites Holdings International, Inc. Exlites Holdings International, Inc. was operated in Japan for a number of years before moving to the United States. The Company's products are sold online and through the company's affiliate and distribution programs. The Company is dedicated to offering medical equipment to hospitals, assisted living facilities and to private individuals who seek quality medical equipment at cost effective prices. The Company's website is at www.exlitesmedical.com.

Forward-Looking Statements - Statements about the Company's future expectations and all other statements in this press release other than historical facts, are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. The Company intends that such forward-looking statements be subject to the safe harbors created thereby. The above information contains information relating to the Company that is based on the beliefs of the Company and/or its management, as well as assumptions made by any information currently available to the Company or its management. When used in this document, the words "anticipate," "estimate," "expect," "intend," "plans," "projects," and similar expressions, as they relate to the Company or its management, are intended to identify forward-looking statements. Such statements reflect the current view of the Company regarding future events and are subject to certain risks, uncertainties and assumptions, including the risks and uncertainties noted. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove to be incorrect, actual results may vary materially from those described herein as anticipated, believed, estimated, expected, intended or projected. In each instance, forward-looking information should be considered in light of the accompanying meaningful cautionary statements herein. Factors that could cause results to differ include, but are not limited to, successful performance of internal plans, the impact of competitive services and pricing and general economic risks and uncertainties.

(1) 2013 Frost & Sullivan Global Medical Devices Outlook.

Contact Information